Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Hangyi Yan

Dr. Hangyi Yan

Scientific Review Officer



Biography

Division:
Division of Basic and Integrative Biological Sciences DTCS
Review Branch:
Respiratory, Cardiac, and Circulatory Sciences RCCS

Dr. Yan received her Ph.D. in biology from Johns Hopkins University. Her dissertation research at the National Cancer Institute (NCI) focused on immuno-oncology to understand how host immunity affects metastasis. For her post-doctoral training at the Food and Drug Administration (FDA), Dr. Yan established humanized mouse models to predict immunotoxicity of biologics. Prior to joining CSR, Dr. Yan was a policy analyst with a focus on device determination and device classification at the Center for Devices and Radiological Health (CDRH), FDA. She also served as a scientific reviewer for hematology in vitro diagnostic medical devices at CDRH/FDA.

 

Last updated: 09/19/2025 05:03